{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:13:37Z","timestamp":1791900817409,"version":"4.3.4"},"reference-count":55,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.revmed.2007.03.004","type":"journal-article","created":{"date-parts":[[2007,4,13]],"date-time":"2007-04-13T07:48:54Z","timestamp":1176450534000},"page":"603-612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Nouvelles classifications et\u00a0physiopathologie des\u00a0myopathies inflammatoires"],"prefix":"10.1016","volume":"28","author":[{"given":"O.","family":"Benveniste","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Dubourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Herson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2007.03.004_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10\u201312 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.revmed.2007.03.004_bib2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2007.03.004_bib3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.revmed.2007.03.004_bib4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":"A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups","volume":"70","author":"Love","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2007.03.004_bib5","first-page":"581","article-title":"Classification and diagnostic criteria for polymyositis and dermatomyositis","volume":"22","author":"Medsger","year":"1995","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.revmed.2007.03.004_bib6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.61.3.316","article-title":"Polymyositis: an overdiagnosed entity","volume":"61","author":"Van der Meulen","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2007.03.004_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/s-2002-33047","article-title":"Misunderstandings, misperceptions, and mistakes in the management of the inflammatory myopathies","volume":"22","author":"Kissel","year":"2002","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.revmed.2007.03.004_bib8","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/00019052-200110000-00007","article-title":"Inflammatory muscle diseases","volume":"14","author":"Hilton-Jones","year":"2001","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.revmed.2007.03.004_bib9","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/archderm.1995.01690240035006","article-title":"Dermatomyositis without muscle weakness. Long-term follow-up of 12 patients without systemic corticosteroids","volume":"131","author":"Cosnes","year":"1995","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.revmed.2007.03.004_bib10","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0889-857X(02)00029-7","article-title":"Genetic and environmental risk factors for idiopathic inflammatory myopathies","volume":"28","author":"Reed","year":"2002","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.revmed.2007.03.004_bib11","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/ar1862","article-title":"In adult onset myositis, the presence of interstitial lung disease and myositis specific\/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype","volume":"8","author":"Chinoy","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.revmed.2007.03.004_bib12","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1046\/j.1523-1747.2002.19608.x","article-title":"Mannose binding lectin (MBL) polymorphisms associated with low MBL production in patients with dermatomyositis","volume":"119","author":"Werth","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.revmed.2007.03.004_bib13","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1046\/j.1523-1747.2002.01869.x","article-title":"Associations of tumor necrosis factor alpha and HLA polymorphisms with adult dermatomyositis: implications for a unique pathogenesis","volume":"119","author":"Werth","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.revmed.2007.03.004_bib14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0046-8177(86)80180-0","article-title":"Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies","volume":"17","author":"Engel","year":"1986","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.revmed.2007.03.004_bib15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00005072-197501000-00005","article-title":"Dermatomyostis of childhood, ultrastructural alteratious of muscle and intramuscular blood vessels","volume":"34","author":"Banker","year":"1975","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.revmed.2007.03.004_bib16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM198602063140601","article-title":"Microvascular deposition of complement membrane attack complex in dermatomyositis","volume":"314","author":"Kissel","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.revmed.2007.03.004_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00000372-198808000-00003","article-title":"Immunoperoxidase technique on paraffin sections fails to demonstrate immunoglobulin deposition in cutaneous lesions from patients with dermatomyositis","volume":"10","author":"Roebker","year":"1988","journal-title":"Am. J. Dermatopathol."},{"key":"10.1016\/j.revmed.2007.03.004_bib18","first-page":"737","article-title":"Anti-vascular endothelial cell antibodies (AECA): comparison of two assay methods and clinical applications","volume":"62","author":"Meyer","year":"1995","journal-title":"Rev. Rhum. Engl. Ed"},{"key":"10.1016\/j.revmed.2007.03.004_bib19","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.revmed.2007.03.004_bib20","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/art.1780280711","article-title":"The association between Mi-2 antibodies and dermatomyositis","volume":"28","author":"Targoff","year":"1985","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.revmed.2007.03.004_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/08916930400022681","article-title":"Anti-Mi-2 antibodies","volume":"38","author":"Ghirardello","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.revmed.2007.03.004_bib22","first-page":"395","article-title":"Significance of Mi-2 autoantibodies in polymyositis and dermatomyositis","volume":"25","author":"Roux","year":"1998","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.revmed.2007.03.004_bib23","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.21023","article-title":"Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis","volume":"52","author":"Sato","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.revmed.2007.03.004_bib24","first-page":"279","article-title":"Myopathies inflammatoires idiopathiques","volume":"21","author":"Figarella-Branger","year":"2001","journal-title":"Ann. Pathol."},{"key":"10.1016\/j.revmed.2007.03.004_bib25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.410270402","article-title":"Microvascular changes in early and advanced dermatomyositis: a quantitative study","volume":"27","author":"Emslie-Smith","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.revmed.2007.03.004_bib26","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1212\/WNL.58.12.1779","article-title":"Differential expression of chemokines in inflammatory myopathies","volume":"58","author":"De Bleecker","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2007.03.004_bib27","first-page":"801","article-title":"Immunohistochemical analysis of adhesion molecule expression on muscle biopsy specimens from patients with juvenile dermatomyositis","volume":"31","author":"Sallum","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.revmed.2007.03.004_bib28","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.4049\/jimmunol.167.6.3521","article-title":"Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients","volume":"167","author":"Benveniste","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.revmed.2007.03.004_bib29","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/ana.20293","article-title":"Long-term persistence of clonally expanded T cells in patients with polymyositis","volume":"56","author":"Benveniste","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.revmed.2007.03.004_bib30","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00002281-200011000-00002","article-title":"Update on the genetics of the idiopathic inflammatory myopathies","volume":"12","author":"Shamim","year":"2000","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.revmed.2007.03.004_bib31","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","article-title":"Polymyositis, dermatomyositis and inclusion-body myositis","volume":"325","author":"Dalakas","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.revmed.2007.03.004_bib32","first-page":"1178","article-title":"Immunocytochemical study of CD45 T cell isoforms in inflammatory myopathies","volume":"146","author":"De Bleecker","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.revmed.2007.03.004_bib33","doi-asserted-by":"crossref","first-page":"9209","DOI":"10.1073\/pnas.97.16.9209","article-title":"Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies","volume":"97","author":"Nagaraju","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.revmed.2007.03.004_bib34","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/ana.410290509","article-title":"Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies","volume":"29","author":"Hohlfeld","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.revmed.2007.03.004_bib35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ana.410190203","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. III: Immunoelectron microscopy aspects of cell-mediated muscle fiber injury","volume":"19","author":"Arahata","year":"1986","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.revmed.2007.03.004_bib36","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1172\/JCI118749","article-title":"Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis","volume":"97","author":"Goebels","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.revmed.2007.03.004_bib37","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/00005072-199612000-00003","article-title":"MHC class I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, dermatomyositis, and inclusion body myositis","volume":"55","author":"Schneider","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.revmed.2007.03.004_bib38","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.4049\/jimmunol.167.7.4051","article-title":"Clonal biases of peripheral CD8 T cell repertoire directly reflect local inflammation in polymyositis","volume":"167","author":"Nishio","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.revmed.2007.03.004_bib39","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00019052-200210000-00002","article-title":"Inclusion-body myositis and myopathies: different etiologies, possibly similar pathogenic mechanisms","volume":"15","author":"Askanas","year":"2002","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.revmed.2007.03.004_bib40","first-page":"240","article-title":"Inclusion body myositis","volume":"25","author":"Yunis","year":"1971","journal-title":"Lab. Invest."},{"key":"10.1016\/j.revmed.2007.03.004_bib41","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1212\/WNL.55.9.1385","article-title":"Epidemiology of inclusion body myositis in the Netherlands: a nationwide study","volume":"55","author":"Badrising","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2007.03.004_bib42","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1212\/01.WNL.0000148588.15052.4C","article-title":"Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis","volume":"63","author":"Badrising","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2007.03.004_bib43","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1006\/mcne.2001.0972","article-title":"Beta-amyloid peptide expression is sufficient for myotube death: implications for human inclusion body myopathy","volume":"17","author":"Querfurth","year":"2001","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.revmed.2007.03.004_bib44","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/brain\/awl020","article-title":"Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis","volume":"129","author":"Dimitri","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.revmed.2007.03.004_bib45","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1093\/brain\/123.10.2030","article-title":"Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time. Studies in repeated muscle biopsies","volume":"123","author":"Amemiya","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.revmed.2007.03.004_bib46","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/art.21103","article-title":"Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction","volume":"52","author":"Nagaraju","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.revmed.2007.03.004_bib47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1097-4598(199801)21:1<115::AID-MUS15>3.0.CO;2-2","article-title":"Immune-mediated conditions and antibodies associated with sporadic inclusion body myositis","volume":"21","author":"Koffman","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.revmed.2007.03.004_bib48","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/mus.20693","article-title":"Myopathy associated with anti-signal recognition peptide antibodies: Clinical heterogeneity contrasts with stereotyped histopathology","volume":"35","author":"Dimitri","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.revmed.2007.03.004_bib49","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(02)08220-X","article-title":"Multiple sclerosis","volume":"359","author":"Compston","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2007.03.004_bib50","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jnnp.73.4.420","article-title":"Myopathy with antibodies to the signal recognition particle: clinical and pathological features","volume":"73","author":"Miller","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.revmed.2007.03.004_bib51","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s11926-002-0089-7","article-title":"Idiopathic inflammatory myopathy: autoantibody update","volume":"4","author":"Targoff","year":"2002","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.revmed.2007.03.004_bib52","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/304177a0","article-title":"Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity","volume":"304","author":"Mathews","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.revmed.2007.03.004_bib53","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/bmj.289.6438.151","article-title":"Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease","volume":"289","author":"Bernstein","year":"1984","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"10.1016\/j.revmed.2007.03.004_bib54","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/jnnp.68.4.472","article-title":"Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres","volume":"68","author":"Mozaffar","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.revmed.2007.03.004_bib55","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.nmd.2006.03.002","article-title":"Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP)","volume":"16","author":"Arlet","year":"2006","journal-title":"Neuromuscul. Disord."}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866307001361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866307001361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:21:23Z","timestamp":1759335683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866307001361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0248866307001361"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2007.03.004","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nouvelles classifications et\u00a0physiopathologie des\u00a0myopathies inflammatoires","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2007.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}